Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADHD
Pharma
Corium sells off ADHD drug Azstarys to Collegium for $650M-plus
Collegium will pay $650 million to acquire ADHD drug Azstarys from privately held Corium. The deal includes $135 million in potential milestones.
Kevin Dunleavy
Mar 19, 2026 11:27am
Collegium enrolls Paris Hilton in Jornay PM ADHD campaign
Mar 4, 2026 3:33pm
Otsuka awareness campaign urges HCPs to see 'All of ADHD'
Feb 9, 2026 12:22pm
Pfizer, Tris settle ADHD drug claims with $41.5M in Texas
Nov 20, 2025 11:35am
Aurobindo acquires US drugmaker Lannett for $250M
Aug 7, 2025 9:35am
Supernus casts Busy Philipps in Qelbree push for women with ADHD
May 21, 2025 10:52am
